Embryonic stem cells prevent developmental cardiac defects in mice

Diego Fraidenraich1, Robert Benezra

  • 1Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. fraidend@mskcc.org

Insights

Embryonic stem cells (ESCs) not only repair heart tissue but also secrete factors that correct gene expression in surrounding cells. This study shows ESCs can prevent and correct cardiac defects in Id knockout mouse embryos.

Area of Science:

  • Stem cell biology
  • Developmental biology
  • Cardiovascular research

Background:

  • Embryonic stem cells (ESCs) show therapeutic potential for tissue repair.
  • Cardiac defects in Id (inhibitor of DNA binding) gene knockout (KO) mouse embryos are lethal.
  • Understanding ESCs' paracrine effects is crucial for regenerative medicine.

Purpose of the Study:

  • To investigate the therapeutic potential of ESCs in correcting cardiac defects.
  • To identify the secreted factors responsible for ESC-mediated cardiac repair.
  • To elucidate the mechanisms by which ESCs influence gene expression in defective tissues.

Main Methods:

  • Injection of ESCs into preimplantation Id KO mouse embryos.
  • Analysis of cardiac morphology and gene expression profiles in treated embryos.
  • Identification of secreted factors using biochemical assays.

Main Results:

  • ESC injection into preimplantation embryos fully prevented cardiac defects and corrected gene expression in Id KO hearts.
  • ESC injection into expectant mothers only partially rescued cardiac defects.
  • Insulin-like growth factor I and Wnt5a were identified as key secreted factors mediating long-range and short-range effects, respectively.

Conclusions:

  • ESCs possess a dual capacity to repopulate damaged tissue and secrete factors that correct cellular gene expression.
  • Secreted factors like IGF-I and Wnt5a play critical roles in ESC-mediated cardiac repair.
  • This research highlights novel therapeutic strategies for congenital heart defects using ESC-derived factors.